Coronavirus/COVID-19 Update

Published date05 March 2020
Subject MatterAcquisitions,SEC,Mergers,Derivatives,OSHA,Life Sciences,Disclosure Requirements,CDC,Publicly-Traded Companies,Cybersecurity,Employment Policies,Force Majeure Clause,Anti-Discrimination Policies,Equity Securities,Global Economy,Capital Markets,Business Interruption,Supply Chain,Corporate Restructuring,Public Safety,Securities Litigation,Commercial Contracts,Public Health,Leveraged Finance,Virtual Meetings,Coronavirus
AuthorBrian V. Breheny,Marc S. Gerber,Richard J. Grossman,John T. Bentivoglio,Jennifer L. Bragg,Stuart D. Levi,Jay Kasner,David Kavanagh,Yossi Vebman,Julie Bédard,Susan Saltzstein,Scott Musoff,Maya Florence,Karen Corman,David Schwartz,Anne Villanueva,Paul Schnell,Christine Okike,Michael Leiter,Ryan Adams,Paul Leake,Blake Grady,Karen Corallo,Lisa Laukitis,Stephanie Teicher,William (Bill) McConagha
Law FirmSkadden, Arps, Slate, Meagher & Flom LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT